Company / Goodwill
ADMA Biologics, Inc. Goodwill History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Goodwill
$3.5M
FY2025
5-year range
$3.5M / $3.5M
FY2021-FY2025
Trend
+0.0%
vs FY2024
Sector context
#64 of 75
Health Care
What the data says
ADMA Biologics, Inc.'s goodwill of $4M is lower than 85% of companies in the Health Care sector (FY2025).
Based on SEC 10-K filings.
$4M in FY2025 with a 5-year CAGR of +0.0%.
Remained stable around $4M over the past 2 years.
Health Care sector context is included.
Goodwill over time
Growth rates
- 3-Year CAGR
- +0.0%
- 5-Year CAGR
- +0.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 15% in Health CareTop 85% of 75This company $3.5M Sector average $4.0B
▼
-99.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +0.0%, indicating consistent growth.
- In FY2025, goodwill increased 0.0% year-over-year.
- Ranks #64 out of 75 companies in the Health Care sector.
- Lowest goodwill in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 3.37 (safe zone, above 2.9 threshold)
- Strong profit margin: 46.4%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | GoodwillValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.5M | +0.0% |
| FY2024 | $3.5M | +0.0% |
| FY2023 | $3.5M | +0.0% |
| FY2022 | $3.5M | +0.0% |
| FY2021 | $3.5M | +0.0% |
| FY2020 | $3.5M | +0.0% |
| FY2019 | $3.5M | +0.0% |
| FY2018 | $3.5M | - |
| FY2017 | $0 | - |
| FY2016 | $0 | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026